A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering ...
From chart-topping beats to a life-altering diagnosis, Ugandan hitmaker Didi faced viral stigma and chose to fight back, ...
Twenty-eight people have been diagnosed with HIV/AIDS, and one person died from HIV infection in Rajshahi in the past 11 ...
If the test does show a positive result for HIV antibodies, the SHA recommends taking a standard HIV test from a health-care ...
On World AIDS Day, advocates warn federal cuts could reverse progress. Carole Treston had been a nurse early in her career when she and her mother traveled to Washington, D.C., and saw the AIDS ...
The findings of this study are valuable as it demonstrates that when treatment is initiated during acute infection, HIV specific CD8 T cell responses are maintained long term and continued ...
If you have unprotected sex or you've got more than one partner, pre-exposure prophylaxis (PrEP) is your best defense against HIV, the virus that causes AIDS. When you take PrEP the right way, it's ...
Expanding reach to populations in Europe not currently using PrEP: Researchers will present the strategies that supported the recruitment of people in high-priority populations across France and the ...
Approval marks first and only twice-yearly option available in the United States for PrEP. HealthDay News — The U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable ...
Sample blood collection tube with HIV test label on HIV infection screening test form. (Photo credit: Shutterstock.com / Room's Studio) A non-reactive HIV test result generally means good news – you ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo ® (lenacapavir)—the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback